The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial
Philip C. Spinella, Kelly Bochicchio, Kimberly A. Thomas, Amanda Staudt, Susan M. Shea, Anthony E. Pusateri, Douglas Schuerer, Jerrold H. Levy, Andrew P. Cap, Grant Bochicchio
Dive into the research topics of 'The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial'. Together they form a unique fingerprint.